Velocity11是生命科學實驗室自動化和機器人解決方案的領先廠商。 安捷倫科技有限公司（NYSE: A）和Velocity11公司于2007年11月7日共同宣布他們已經簽訂了安捷倫收購Velocity11的最終協議。Velocity11是一家私人公司，在生命科學市場上其是自動化液體處理和試驗室機器人的領導廠商。具體細節未被透露，此收購預期在30天到60天內完成。 此收購將使安捷倫能夠提供更多的全面的工作流程解決方案，為其在醫藥、生物科技和科學研究市場。Velocity11主要是設計、制造和銷售機器人解決方案，從單機儀表開始到高級自動化解決方案再到大型多扶手機器人系統。公司還開發了世界級的軟件用于控制機器人。Velocity11的技術通過廣泛的應用將加強安捷倫自動化樣品準備解決方案。 安捷倫生命科學和解決方案部的副總裁Nick Roelofs說：“Velocity11在技術創新、產品質量和服務方面有著極好的聲譽，他是實驗室解決方案的領導者。同時地，我們可以為客戶提供一套用于自動化的全面工作流程，幫助加速解決阻力和遺傳方面的研究。在收購完成之時，用戶將斷續收到來自Velocity11的個性化服務，還加上來自安捷倫強大的網絡服務和支持。” Velocity11的首席執行官Rob Nail說：“我們很高興能加入像安捷倫擁有如此完整公司文化、產品生產線、極高客戶滿意度和全套自動化工作流程解決方案模式的公司。安捷倫的全球架構和嘗試應有將允許我們繼續提高我們提供給我們客戶的服務、創新方面的新方向以迅速擴展我們的解決方案。” 安捷倫將為Velocity11的約150名員工提供的工作。Velocity11成立于1999年，總部位于加利福尼亞Menlo Park，第二個辦公室位于英國哈福德郡的Melbourn，為美國和西歐提供全面的服務支持。 Velocity11被認為是在硅谷企業和北美區域中發展最快企業中的一個。2006年，Velocity11被Deloitte列入美國快速發展企業名單之中。 [FONT=times] original text [/FONT] [font=times][Color=#708090]Agilent Technologies Inc. （NYSE: A） and Velocity11 today announced that they have signed a definitive agreement for Agilent to acquire Velocity11. Velocity11, privately held, is a leader in automated liquid handling and laboratory robotics for the life science market. Financial details were not disclosed. The acquisition is expected to be final in 30 to 60 days, subject to certain closing conditions. The acquisition will enable Agilent to offer a more comprehensive suite of workflow solutions to its life science customers in the pharmaceutical, biotech and academic research markets. Velocity11 designs, manufactures and markets robotic solutions that range from standalone instrumentation to bench-top automation solutions to large, multi-armed robotic systems. The company also develops world-class software to control the robotics. Velocity11‘s technology will strengthen Agilent‘s offering of automated sample-preparation solutions across a broad range of applications. "Velocity11 is a market leader in lab automation with a solid reputation for innovative technology, quality products and superb customer service," said Nick Roelofs, vice president of Agilent‘s Life Science Systems and Solutions Unit. "Together, we can offer customers a comprehensive set of workflow solutions with increased levels of automation, which can help speed drug discovery and genetic research. When the acquisition is final, customers will continue to experience the same personalized customer service they‘ve come to expect from Velocity11, with the addition of Agilent‘s strong network of global service and support." "We are very excited to be joining Agilent and to have found a company with such a complementary culture, product line, commitment to customer satisfaction and vision for providing complete automated workflow solutions," said Rob Nail, Velocity11‘s CEO. "The ability to leverage Agilent‘s global infrastructure and deep applications focus will allow us to continue to improve the services we provide our customers, innovate in new directions, and rapidly expand our reach worldwide." Agilent is offering jobs to substantially all of Velocity11‘s approximately 150 employees worldwide. Headquartered in Menlo Park, Calif., Velocity11 has a second office in Melbourn, Hertfordshire, U.K., with field sales and support offered throughout the U.S. and western Europe. The company was established in 1999. Velocity11 has been recognized as one of the fastest growing companies in Silicon Valley （"Silicon Valley Fast 50" list） and in North America （"Technology Fast 500" list and Inc. 500 list）. In 2006, Velocity11 was named to Deloitte‘s "Fastest Growing U.S. Tech Company" list.[/color][/font]